Chenqi Technology Ltd (9680.HK)
14.2
(0.0%)
14.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 2.16 Billion | 1.36 Billion | 1.01 Billion |
| Cost of Revenue | 2.31 Billion | 1.51 Billion | 1.25 Billion |
| Gross Profit | -150.44 Million | -145.91 Million | -245.11 Million |
| Operating Expenses | 443.4 Million | 428.18 Million | 445.32 Million |
| Selling, General and Administrative Expenses | 211.74 Million | 197.56 Million | 251.66 Million |
| Research and Development Expenses | 118.94 Million | 105.4 Million | 116.62 Million |
| Other Expenses | 112.71 Million | -10.45 Million | -467 Thousand |
| Cost and Expenses | 2.75 Billion | 1.94 Billion | 1.7 Billion |
| Operating Income | -593.85 Million | -561.63 Million | -683.47 Million |
| Interest Expense | 2.61 Million | 2.64 Million | 1.15 Million |
| Income Tax Expense | - | -10.4 Million | 3.32 Million |
| Earnings before Tax | -692.79 Million | -626.78 Million | -684.62 Million |
| Net Income | -692.79 Million | -626.78 Million | -684.62 Million |
| Earnings Per Share Basic | -7.69 | - | - |
| Earnings Per Share Diluted | -7.69 | - | - |
| Weighted Average Shares Outstanding | 90.03 Million | - | - |
| Weighted Average Shares Outstanding (Diluted) | 90 Million | - | - |
| Gross Margin | -0.07 | -0.11 | -0.24 |
| EBIT Margin | -0.30 | -0.40 | -0.66 |
| Profit Margin | -0.32 | -0.46 | -0.68 |
| EBITDA | -654.97 Million | -601.37 Million | -668.9 Million |
| Earnings Before Tax Margin | -0.27 | -0.41 | -0.67 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 518.52 Million | 518.52 Million | 2.16 Billion | 456.31 Million | 456.31 Million | 1.36 Billion |
| Cost of Revenue | 534.74 Million | 534.74 Million | 2.31 Billion | 491.65 Million | 491.65 Million | 1.51 Billion |
| Gross Profit | -16.22 Million | -16.22 Million | -150.44 Million | -35.34 Million | -35.34 Million | -145.91 Million |
| Operating Expenses | 111.72 Million | 111.72 Million | 455.27 Million | 119.47 Million | 119.47 Million | 428.18 Million |
| Selling, General and Administrative Expenses | 76.58 Million | 76.58 Million | - | 92.03 Million | 92.03 Million | - |
| Research and Development Expenses | 36.76 Million | 36.76 Million | - | 28.83 Million | 28.83 Million | - |
| Other Expenses | -1.62 Million | -1.62 Million | -63.79 Million | -1.39 Million | -1.39 Million | -10.45 Million |
| Cost and Expenses | 646.47 Million | 646.47 Million | 2.76 Billion | 611.13 Million | 611.13 Million | 1.94 Billion |
| Operating Income | -127.94 Million | -127.94 Million | -593.85 Million | -154.82 Million | -154.82 Million | -561.63 Million |
| Interest Expense | - | - | 2.61 Million | - | - | 2.64 Million |
| Income Tax Expense | -2.27 Million | -2.27 Million | -64.5 Million | -2.94 Million | -2.94 Million | -10.4 Million |
| Earnings before Tax | -165.81 Million | -165.81 Million | -692.79 Million | -172.7 Million | -172.7 Million | -626.78 Million |
| Net Income | -165.81 Million | -165.81 Million | -692.79 Million | -172.7 Million | -172.7 Million | -626.78 Million |
| Earnings Per Share Basic | -1.84 | -1.84 | - | -1.92 | -1.92 | - |
| Earnings Per Share Diluted | -1.84 | -1.84 | - | -1.92 | -1.92 | - |
| Weighted Average Shares Outstanding | 90.3 Million | 90.3 Million | - | 90 Million | 90 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 90 Million | 90 Million | - | 90 Million | 90 Million | - |
| Gross Margin | -0.03 | -0.03 | -0.07 | -0.08 | -0.08 | -0.11 |
| EBIT Margin | -0.24 | -0.24 | - | -0.34 | -0.34 | - |
| Profit Margin | -0.32 | -0.32 | -0.32 | -0.38 | -0.38 | -0.46 |
| EBITDA | -125.54 Million | -125.54 Million | - | -154.9 Million | -154.9 Million | - |
| Earnings Before Tax Margin | -0.25 | -0.25 | -0.27 | -0.34 | -0.34 | -0.41 |
HLBBF
3474
BIOWKS
DEXSF
4040
GTK